Cargando…

Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy

Cardiovascular disease is the leading cause of death worldwide and bears an immense economic burden. Late-stage heart failure often requires total heart transplantation; however, due to donor shortages and lifelong immunosuppression, alternative cardiac regenerative therapies are in high demand. Hum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silver, Sophia E., Barrs, Ryan W., Mei, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606657/ https://www.ncbi.nlm.nih.gov/pubmed/34820426 http://dx.doi.org/10.3389/fcvm.2021.707890

Ejemplares similares

The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells
por: Soma, Yusuke, et al.
Publicado: (2021)

Development of a Contractile Cardiac Fiber From Pluripotent Stem Cell Derived Cardiomyocytes
por: Hansen, Katrina J., et al.
Publicado: (2018)

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022)

Co-transplantation of Mesenchymal Stromal Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Cardiac Function After Myocardial Damage
por: Neef, Klaus, et al.
Publicado: (2022)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
por: Hamledari, Homa, et al.
Publicado: (2022)

In vivo tracking transplanted cardiomyocytes derived from human induced pluripotent stem cells using nuclear medicine imaging
por: Saito, Yukihiro, et al.
Publicado: (2023)

Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020)

Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes
por: Reilly, Louise, et al.
Publicado: (2022)

Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports
por: Kawamura, Takuji, et al.
Publicado: (2023)

Reawakening the Intrinsic Cardiac Regenerative Potential: Molecular Strategies to Boost Dedifferentiation and Proliferation of Endogenous Cardiomyocytes
por: Bongiovanni, Chiara, et al.
Publicado: (2021)

Trends and Limitations in the Assessment of the Contractile Properties of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Patients With Dilated Cardiomyopathy
por: Ito, Masamichi, et al.
Publicado: (2020)

Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Song, Yongfei, et al.
Publicado: (2022)

Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation
por: Zhong, Rujia, et al.
Publicado: (2022)

Changing Metabolism in Differentiating Cardiac Progenitor Cells—Can Stem Cells Become Metabolically Flexible Cardiomyocytes?
por: Malandraki-Miller, Sophia, et al.
Publicado: (2018)

Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial
por: Zhang, He, et al.
Publicado: (2022)

Conventional rigid 2D substrates cause complex contractile signals in monolayers of human induced pluripotent stem cell‐derived cardiomyocytes
por: Huethorst, Eline, et al.
Publicado: (2021)

Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Park, Misun, et al.
Publicado: (2018)

Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes
por: Wu, Peng, et al.
Publicado: (2021)

Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy
por: Morita, Yuika, et al.
Publicado: (2022)

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
por: Tanosaki, Sho, et al.
Publicado: (2021)

Gene therapy during ex situ heart perfusion: a new frontier in cardiac regenerative medicine?
por: Vervoorn, Mats T., et al.
Publicado: (2023)

Induced pluripotent stem cell-derived smooth muscle cells to study cardiovascular calcification
por: Atkins, Samantha K., et al.
Publicado: (2022)

Extracellular matrix cues regulate the differentiation of pluripotent stem cell-derived endothelial cells
por: Noh, Kyung Mu, et al.
Publicado: (2023)

Cardiomyocyte—Endothelial Cell Interactions in Cardiac Remodeling and Regeneration
por: Talman, Virpi, et al.
Publicado: (2018)

Cardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac Repair
por: Gomez, Ingrid, et al.
Publicado: (2018)

Age Is Relative—Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality
por: Strässler, Elisabeth Tamara, et al.
Publicado: (2018)

Development and Application of Endothelial Cells Derived From Pluripotent Stem Cells in Microphysiological Systems Models
por: Kennedy, Crystal C., et al.
Publicado: (2021)

STAT3 and Endothelial Cell—Cardiomyocyte Dialog in Cardiac Remodeling
por: Zouein, Fouad A., et al.
Publicado: (2019)

Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming
por: Sadahiro, Taketaro
Publicado: (2019)

Recent Insight on the Non-coding RNAs in Mesenchymal Stem Cell-Derived Exosomes: Regulatory and Therapeutic Role in Regenerative Medicine and Tissue Engineering
por: Pant, Tarun, et al.
Publicado: (2021)

Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
por: Selvakumar, Dinesh, et al.
Publicado: (2022)

Cardiomyocyte proliferation: paving the way for cardiac regenerative medicine without stem cell transplantation
por: Ventura, Carlo
Publicado: (2010)

Induced pluripotent stem cell for modeling Pompe disease
por: Huang, Wenjun, et al.
Publicado: (2022)

Alteration of N(6)-Methyladenosine mRNA Methylation in a Human Stem Cell-Derived Cardiomyocyte Model of Tyrosine Kinase Inhibitor-Induced Cardiotoxicity
por: Ma, Yan, et al.
Publicado: (2022)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Resistin-Like Molecule α Dysregulates Cardiac Bioenergetics in Neonatal Rat Cardiomyocytes
por: Tao, Bingdong, et al.
Publicado: (2021)

Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
por: Itzhaki, Ilanit, et al.
Publicado: (2011)

In vivo multi-modality tracking of the regenerative effects of the human induced pluripotent stem cell-derived cardiomyocytes (iCMs)
por: Mahmoudi, Morteza, et al.
Publicado: (2015)

Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Fatica, Erica M., et al.
Publicado: (2019)

Cardiomyocyte Specific Deletion of ADAR1 Causes Severe Cardiac Dysfunction and Increased Lethality
por: el Azzouzi, Hamid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2952n3n6srv8snm9mutgnerees